ViraxClear Plans to Launch ‘Back to Work’ Employee Protection Equipment (EPE) Kit
May 28 2020 - 5:00AM
Global Care Capital Corp. (CSE:
HLTH, FRANKFURT:
L6V1) (the
“
Company” or “
Global Care”) a
global investment company which engages in early stage investment
opportunities in private and public companies, is pleased to
announce that its portfolio company, ViraxClear, through its joint
venture, Shanghai Biotechnology Devices Ltd.
(“
SBD”), plans to launch an Employee Protection
Equipment (EPE) kit, which will help business owners protect their
employees from the transmission of viral infections, such as
COVID-19.
Dr Tomasz George, Chief Scientific Officer of
ViraxClear states, “Governments, companies and employees worldwide
are keen to resume trading, get back to work, and get the economy
moving again, but there is a real concern for workers safety and
this must be ensured before any increases in operations. Social
distancing and training on infection control are important, as is
having effective protective equipment and cleaning products. A
scientifically curated kit of key protective equipment will be
crucial in allowing employees back to work by creating conditions
for an acceptable level of safety in the workplace. It is crucial
that employers can provide enough safety equipment for their staff
to curb, and limit as far as possible, the transmission of
COVID-19.”
“In order to do this, there needs to be a
plentiful and continuous supply of PPE such as masks, gloves and
antiviral wipes as well as the technology to analyse symptoms, with
the use of devices such as infrared thermometers and oximeters.
Whether someone works in an office, a construction site, a
restaurant or a clinic, their safety is the priority and the only
way work can resume for them, their colleagues, clients or
customers is to have the appropriate knowledge and equipment. As
well as in the workplace itself, employees are being put at risk
during their travel to and from work and will require an ample PPE
supply from their employers.”
“The global demand for PPE has never been
greater and the ViraxClear EPE kit will help bridge the gap in
allowing employers to run their businesses again by letting
employees return to work safely.”
The Product
Customers will receive their ViraxClear EPE kit,
which includes the following medical devices with the kit and PPE
on a subscription refill basis:
Infrared Thermometer – The
thermometers do not require contact with a person and can swiftly
measure temperature from 1cm-5cm from the forehead. These are
particularly useful for use in public places like a hotel, airport,
factory or office. These are battery-operated, handy and easy to
use thermometers, which do not require any trained technicians.
Whilst they are by no means definitively accurate in the detection
of COVID-19, they are widely being used across the world to detect
potential symptomatic COVID-19 carriers.
Pulse Oximeter – These
easy-to-use devices simply clip on to your finger and measure pulse
rate and blood oxygen saturations, which can be key indicators in
viral infection.
KN95 Masks – ViraxClear
has developed its’ own range of KN95, FDA Registered and CE marked
masks, which may be comfortably worn for hours.
Disposable 3 Ply Masks –
ViraxClear has developed its’ own range of FDA Registered and CE
marked 3-ply disposable masks, which are particularly helpful
travelling to and from work.
Gloves – To reduce the risk of
transmitting potential pathogens, particularly during travel to and
from the workplace.
Antimicrobial Hand Wipes –
these wipes include active agents to kill certain types of
potential pathogens
Advantages
ViraxClear EPE kit works to help keep the
workplace safe in three ways:
- Limiting Contact Transmission:
The antimicrobial wipes and gloves limit the transmission of
germs from direct and indirect contact with the environment around
us to our hands and face. This is applicable both travelling to and
from work and whilst in the workplace.
- Limiting Airborne and Droplet Transmission:
The use of 3-ply masks and KN95 masks can help to minimise the risk
of respiratory viral transmission.
- Detection: Early detection of COVID-19
symptoms is key in limiting the spread of the virus. Pulse
oximeters and infrared thermometers could allow employers to detect
signs of infection and restrict the transmission to others.
Supply and Distribution
Venus Consulting Ltd. will be ViraxClear’s
supplier of the EPE kit components. ViraxClear anticipates it will
be ready to launch this product in early June and will focus on
Europe and North America as key markets.
About ViraxClear
ViraxClear focuses on commercializing novel
products that address significant healthcare needs with a
specific target on the novel coronavirus (COVID-19). The
company’s main focus is marketing its ViraxClear Rapid IgM-IgG
Combined Antibody Test. The ViraxClear Rapid IgM-IgG Combined
Antibody Test for COVID-19 is a lateral flow immunoassay used to
qualitatively detect both early and late marker IgG/IgM
antibodies.
About Global Care
Global Care Capital is a global investment
company which specializes in providing early stage financing to
private and public companies. The Company engages in new, early
stage investment opportunities in previously underdeveloped assets
and obtaining positions in early stage investment opportunities
that adequately reflect the risk profile.
GLOBAL CARE CAPITAL
CORP.:
Company Contact:
Alex Somjen, President & CEO
asomjen@globalcarecapital.com
Neither the CSE nor its regulation
services provider accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Information: This news release
includes certain statements that may be deemed “forward-looking
statements”. The use of any of the words “anticipate”, “continue”,
“estimate”, “expect”, “may”, “will”, “would”, “project”, “should”,
“believe” and similar expressions are intended to identify
forward-looking statements. Although the Company believes that the
expectations and assumptions on which the forward-looking
statements are based are reasonable, undue reliance should not be
placed on the forward-looking statements because the Company can
give no assurance that they will prove to be correct. Since
forward-looking statements address future events and conditions, by
their very nature they involve inherent risks and uncertainties.
These statements speak only as of the date of this News Release.
Actual results could differ materially from those currently
anticipated due to a number of factors and risks including various
risk factors discussed in the Company’s disclosure documents which
can be found under the Company’s profile on www.sedar.com.
Global Care Capital (CSE:HLTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Global Care Capital (CSE:HLTH)
Historical Stock Chart
From Jul 2023 to Jul 2024